Patterns and Determinants of Dementia Pharmacotherapy in a Population-Based Cohort of Home Care Clients

被引:0
作者
Colleen J. Maxwell
Mary Vu
David B. Hogan
Scott B. Patten
Micaela Jantzi
Marie-Jeanne Kergoat
Nathalie Jetté
Susan E. Bronskill
George Heckman
John P. Hirdes
机构
[1] University of Waterloo,School of Pharmacy
[2] University of Waterloo,School of Public Health and Health Systems
[3] University of Calgary,Department of Community Health Sciences and Institute of Public Health
[4] Institute for Clinical Evaluative Sciences,Division of Geriatric Medicine, Department of Medicine
[5] University of Calgary,Centre de recherche, Institut universitaire de gériatrie de Montréal, Département de médecine
[6] Université de Montréal,Department of Clinical Neurosciences and Hotchkiss Brain Institute
[7] University of Calgary,Institute of Health Policy, Management and Evaluation
[8] University of Toronto,Research Institute for Aging
[9] University of Waterloo,undefined
来源
Drugs & Aging | 2013年 / 30卷
关键词
Dementia; Memantine; Rivastigmine; Galantamine; Cognitive Performance Scale;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:569 / 585
页数:16
相关论文
共 159 条
[1]  
Jakobsen M(2011)Costs of informal care for people suffering from dementia: evidence from a Danish survey Dement Geriatr Cogn Dis Extra 1 418-428
[2]  
Poulsen PB(2006)Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer’s disease and other dementias Pharmacoeconomics 24 265-280
[3]  
Reiche T(2011)Net costs of dementia by disease stage Acta Psychiatr Scand 124 384-395
[4]  
Hill J(2012)Making Alzheimer’s and dementia research fit for population Lancet 380 1441-1443
[5]  
Fillit H(2004)The age gap between patients in clinical studies and in the general population: a pitfall for dementia research Lancet Neurol 3 627-630
[6]  
Thomas SK(2004)Representation of patients with dementia in clinical trials of donepezil Can J Clin Pharmacol 11 e274-e285
[7]  
Leicht H(2008)Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia CMAJ 179 1019-1026
[8]  
Heinrich S(2008)Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease CMAJ 179 1279-1287
[9]  
Heider D(2005)Cholinesterase inhibitors for patients with Alzheimer’s disease: systematic review of randomised clinical trials BMJ 331 321-327
[10]  
Brayne C(2008)Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline Ann Intern Med 148 379-397